San Francisco, CA, United States of America

Ko-Chuan Lee

This inventor holds 2 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignee: Algen Biotechnologies, Inc.. Active years: 2023-2025.

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2023-2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Ko-Chuan Lee: Innovator in Chemical Compositions

Introduction

Ko-Chuan Lee is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of biotechnology, particularly in the development of chemical compositions and methods for treating diseases. With a total of 2 patents, his work focuses on innovative solutions for serious health conditions.

Latest Patents

Ko-Chuan Lee's latest patents include advancements in CDK9 inhibitors. These patents provide methods for treating diseases or disorders by administering CDK9 inhibitors to subjects in need of treatment. Specifically, the patents address the treatment of cancer, including liver cancer, showcasing the potential impact of his work on oncology.

Career Highlights

Lee is currently associated with Algen Biotechnologies, Inc., where he continues to push the boundaries of research and innovation. His expertise in chemical compositions has positioned him as a key player in the biotechnology sector.

Collaborations

Some of his notable coworkers include Andrei William Konradi and Chun-Hao Huang, who contribute to the collaborative environment that fosters innovation at Algen Biotechnologies.

Conclusion

Ko-Chuan Lee's contributions to the field of biotechnology through his patents and work at Algen Biotechnologies highlight his commitment to advancing medical treatments. His innovative approaches to combating diseases like cancer demonstrate the importance of research and development in improving health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…